GSK-2018682

Nomen chemicum:

4-(4-(5-(5-chloro-6-isopropoxypyridin-3-yl) -1,2,4-oxadiazol-3-yl) acidum butanoicum

SMILES Code:

O=C(O)CCCN1C=CC2=C1C=CC=C2C3=NOC(C4=CC(Cl)=C(OC(C)C)N=C4)=N3

InChi Code:

InChI=1S/C22H21ClN4O4/c1-13(2)30-22-17(23)11-14(12-24-22)21-25-20(26-31-21)16-5-3-6- 18-15(16)8-10-27(18)9-4-7-19(28)29/h3,5-6,8,10-13H,4,7,9H2,1-2H3,(H ,28,29)

InChi Key:

NFIGDBFIDKDNIG-UHFFFAOYSA-N

Keyword:

1034688-30-6；CAS:1034688-30-6；CAS：1034688-30-6；GSK-2018682；GSK 2018682；GSK2018682; 2018682

Solubilitas:Solutum in DMSO

Repono:0 - 4 C ad terminum brevem (dies ad septimanas), vel -20 C ad terminum longi (menses).

Descriptio:

GSK2018682 agonist pro S1P1 et S1P5 receptoribus est.

Target: Agonists ad S1P1 et S1P5 accipientium